Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

← catalyst calendar

NCT05281328 · results posted

Sponsored by Camurus AB (industry) · CAMX.ST — their whole pipeline →.

Phase
Phase 2/3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
71actual
Sites
11
Countries
Belgium, Germany, Netherlands +1

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2022-06-28actualWhen the study began enrolling
Primary completion2025-02-05actualThe date the last participant is measured for the primary outcome — the readout window
Study completionAug 2027estimatedThe whole study's end, after follow-up
First posted2022-03-16actualWhen this record first appeared on the registry
Results posted2026-06-01actualWhen the sponsor posted results to the registry
Record updated2026-06-01actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Polycystic Liver Disease

Interventions

  • Drug: CAM2029 — also filed as octreotide subcutaneous depot
  • Drug: Placebo

Primary outcome

what the primary-completion date above is the date OF
Height-adjusted Total Liver Volume (htTLV)
measured From screening until treatment week 53

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2025-10-20 · 5.7 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-03-31 · 1.3 MB · SAP_001.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · CAMX.ST's whole pipeline · Catalyst calendar · Every registered study · What changed